Operational Medicine Test and Evaluation Cell Salvage Supplemental - (AFMEDCOM)

The Air Force Materiel Command Installation and Mission Support Center is conducting supplemental market research via Request for Information to identify solutions for a cell salvage device capable of performing blood conditioning and autonomous return with flow rate control in austere environments, with final responses due November 16, 2026.

The RFI seeks information on existing FDA-cleared devices and prototypes from large businesses and all categories of small business. Respondents must address 23 essential characteristics and 5 preferences, including FDA approval status or pathway; use of FDA-cleared consumables; real-time fluid pressure monitoring; recovery capability from any orientation within three minutes; user-selectable collection and return rates up to 1500 mL/min; gas exchange with selectable sweep gas flow rates up to 10 L/min; integrated hypothermia prevention through heating; and specific thermal performance (heating 450 cc of fluid from 2°C to 37°C). Manufacturers may respond even if systems do not currently meet all requirements, providing trade-off considerations where applicable.

Place of performance is austere military environments. The applicable NAICS code is 339112 (Surgical and Medical Instrument Manufacturing). Responses must be submitted via email to usaf.detrick.afmra.mbx.sg5t-market@health.mil; questions and answers are due by 5:00 PM CST November 2, 2026, with final responses due by 5:00 PM CST November 16, 2026. The maximum file size is 10 MB. This is a sources sought and market research effort; no contract will be awarded and the government will not reimburse respondents for costs.